Your session is about to expire
← Back to Search
Other
SutureSafe dressings for Scarring
N/A
Waitlist Available
Led By Nick Carr, B.Sc. MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months, 6 months and 1 year post operative
Awards & highlights
Study Summary
The purpose of this study is to evaluate the effect SutureSafe dressings have on reducing scarring from an incision following an elective abdominoplasty (tummy tuck) procedure. The scar will be evaluated using subjective clinical assessment criteria. Each participant in the study will serve as a control and experiential study, since have of the incision will be treated with the gold standard of care and the other half with SutureSafe dressings.
Eligible Conditions
- Scarring
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months, 6 months and 1 year post operative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months, 6 months and 1 year post operative
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change between usual standard of care and experimental dressings at 3 months, 6 months and 1 year, assessed using the Vancouver Scar Score
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SutureSafe dressingsExperimental Treatment1 Intervention
SutureSafe dressing are designed to apply a constant gentle inward pressure on the incision to reduce separating tension on newly formed incisions, stabilizing the healing environment.
Group II: Gold standard of careActive Control1 Intervention
The usual gold standard of wound treatment to prevent scarring is to cover the incision with a self adhesive gauze type dressing (Mepore) covered by paper tape.
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,418 Previous Clinical Trials
2,467,078 Total Patients Enrolled
3 Trials studying Scarring
341 Patients Enrolled for Scarring
Nick Carr, B.Sc. MDPrincipal InvestigatorThe University of British Columbia
Baillie L Redfern, B.Sc., M.ScStudy DirectorThe University of British Columbia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger